The Latin America, Middle East and Africa Clinical Perinatal Software Market is expected to witness market growth of 11.5% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Clinical Perinatal Software Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $9.63 millions by 2031. The Argentina market is showcasing a CAGR of 12.4% during 2024-2031. Additionally, the UAE market would register a CAGR of 10.5% during 2024-2031.
With the increase in maternal and infant mortality rates, there has been a growing emphasis on improving healthcare services for mothers and newborns. As healthcare professionals and governments strive to reduce risks during childbirth, adopting this software has been seen as a crucial step toward achieving these goals.
As healthcare systems shift toward value-based care models, which emphasize patient outcomes over service volume, the adoption of this software becomes essential. The software helps improve outcomes by providing healthcare professionals with real-time insights and analytics, leading to better decision-making and proactive care management.
The UAE heavily invests in healthcare, focusing on digital health solutions like clinical perinatal software to improve maternal and neonatal care. These efforts align with the government’s Vision 2040 and its commitment to enhancing healthcare services. South Africa is increasingly adopting digital health technologies to address maternal and child health challenges, with this software playing a key role in managing high-risk pregnancies. Similarly, South Africa’s healthcare sector is transforming, with growing investments in technology to improve patient care and address pressing healthcare challenges. As the country strives to enhance maternal and child health, this software has become essential for monitoring high-risk pregnancies and improving overall maternal care. Thus, continued investments in healthcare innovation and a growing focus on improving maternal health drive the market's growth.
The Brazil market dominated the LAMEA Clinical Perinatal Software Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $9.63 millions by 2031. The Argentina market is showcasing a CAGR of 12.4% during 2024-2031. Additionally, the UAE market would register a CAGR of 10.5% during 2024-2031.
With the increase in maternal and infant mortality rates, there has been a growing emphasis on improving healthcare services for mothers and newborns. As healthcare professionals and governments strive to reduce risks during childbirth, adopting this software has been seen as a crucial step toward achieving these goals.
As healthcare systems shift toward value-based care models, which emphasize patient outcomes over service volume, the adoption of this software becomes essential. The software helps improve outcomes by providing healthcare professionals with real-time insights and analytics, leading to better decision-making and proactive care management.
The UAE heavily invests in healthcare, focusing on digital health solutions like clinical perinatal software to improve maternal and neonatal care. These efforts align with the government’s Vision 2040 and its commitment to enhancing healthcare services. South Africa is increasingly adopting digital health technologies to address maternal and child health challenges, with this software playing a key role in managing high-risk pregnancies. Similarly, South Africa’s healthcare sector is transforming, with growing investments in technology to improve patient care and address pressing healthcare challenges. As the country strives to enhance maternal and child health, this software has become essential for monitoring high-risk pregnancies and improving overall maternal care. Thus, continued investments in healthcare innovation and a growing focus on improving maternal health drive the market's growth.
List of Key Companies Profiled
- Oracle Corporation
- Koninklijke Philips N.V.
- Trium Analysis Online GmbH
- Edan Instruments, Inc.
- K2 Medical Systems Ltd.
- Arjo AB (Huntleigh Healthcare Ltd.)
- Clinical Computer Systems, Inc. DBA OBIX and OBIX BeCA
- GE HealthCare Technologies, Inc.
- Illumina, Inc.
- Quest Diagnostics Incorporated
Market Report Segmentation
By Product
- Integrated
- Standalone
By Deployment Model
- On-premise
- Cloud
By Application
- Fetal Monitor Data Services
- Workflow Management
- Patient Documentation
By End Use
- Hospitals/Clinics
- Maternity clinics
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Clinical Perinatal Software Market by Product
Chapter 5. LAMEA Clinical Perinatal Software Market by Deployment Model
Chapter 6. LAMEA Clinical Perinatal Software Market by Application
Chapter 7. LAMEA Clinical Perinatal Software Market by End Use
Chapter 8. LAMEA Clinical Perinatal Software Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Oracle Corporation
- Koninklijke Philips N.V.
- Trium Analysis Online GmbH
- Edan Instruments, Inc.
- K2 Medical Systems Ltd.
- Arjo AB (Huntleigh Healthcare Ltd.)
- Clinical Computer Systems, Inc. DBA OBIX and OBIX BeCA
- GE HealthCare Technologies, Inc.
- Illumina, Inc.
- Quest Diagnostics Incorporated
Methodology
LOADING...
